LISATA THERAPEUTICS, INC. Earnings Per Share (Basic)
LISATA THERAPEUTICS, INC. (LSTA) reported Earnings Per Share (Basic) of -$0.32 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-06
- LISATA THERAPEUTICS, INC. earnings per share, basic for the quarter ending 2026-06-30 was -$0.32.
- LISATA THERAPEUTICS, INC. earnings per share, basic for the quarter ending 2026-03-31 was -$0.50.
- LISATA THERAPEUTICS, INC. earnings per share, basic for the quarter ending 2025-09-30 was -$0.49.
- LISATA THERAPEUTICS, INC. earnings per share, basic for the quarter ending 2025-06-30 was -$0.54.
- LISATA THERAPEUTICS, INC. earnings per share, basic for fiscal 2025 was -$1.91.
- LISATA THERAPEUTICS, INC. earnings per share, basic for fiscal 2024 was -$2.40.
- LISATA THERAPEUTICS, INC. earnings per share, basic for fiscal 2023 was -$2.58.
- LISATA THERAPEUTICS, INC. earnings per share, basic for fiscal 2022 was -$10.47.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$0.32 10-Q · filed 2026-08-06 | -$0.82 10-Q · filed 2026-08-06 | ||||||
| 2026-03-31 | -$0.50 10-Q · filed 2026-05-11 | |||||||
| 2025-12-31 | -$1.91 10-K · filed 2026-03-12 | |||||||
| 2025-09-30 | -$0.49 10-Q · filed 2025-11-06 | -$1.58 10-Q · filed 2025-11-06 | ||||||
| 2025-06-30 | -$0.54 10-Q · filed 2026-08-06 | -$1.09 10-Q · filed 2026-08-06 | ||||||
| 2025-03-31 | -$0.55 10-Q · filed 2026-05-11 | |||||||
| 2024-12-31 | -$2.40 10-K · filed 2026-03-12 | |||||||
| 2024-09-30 | -$0.59 10-Q · filed 2025-11-06 | -$1.85 10-Q · filed 2025-11-06 | ||||||
| 2024-06-30 | -$0.61 10-Q · filed 2025-08-07 | -$1.26 10-Q · filed 2025-08-07 | ||||||
| 2024-03-31 | -$0.65 10-Q · filed 2025-05-08 | |||||||
| 2023-12-31 | -$2.58 10-K · filed 2025-02-27 | |||||||
| 2023-09-30 | -$0.65 10-Q · filed 2024-11-12 | -$1.92 10-Q · filed 2024-11-12 | ||||||
| 2023-06-30 | -$0.50 10-Q · filed 2024-08-12 | -$1.28 10-Q · filed 2024-08-12 | ||||||
| 2023-03-31 | -$0.77 10-Q · filed 2024-05-09 | |||||||
| 2022-12-31 | -$10.47 10-K · filed 2024-02-29 | |||||||
| 2022-09-30 | -$7.88 10-Q · filed 2023-11-02 | -$11.28 10-Q · filed 2023-11-02 | ||||||
| 2022-06-30 | -$1.64 10-Q · filed 2023-08-14 | -$0.11 10-Q · filed 2022-08-04 | -$2.69 10-Q · filed 2023-08-14 | -$0.18 10-Q · filed 2022-08-04 | ||||
| 2022-03-31 | -$1.05 10-Q · filed 2023-05-09 | -$0.07 10-Q · filed 2022-05-05 | ||||||
| 2021-12-31 | -$7.45 10-K · filed 2023-03-30 | -$0.50 10-K · filed 2022-03-22 | ||||||
| 2021-09-30 | -$1.74 10-Q · filed 2022-11-10 | -$0.12 10-Q · filed 2021-11-04 | -$5.76 10-Q · filed 2022-11-10 | -$0.38 10-Q · filed 2021-11-04 | ||||
| 2021-06-30 | -$0.10 10-Q · filed 2022-08-04 | -$0.27 10-Q · filed 2022-08-04 | ||||||
| 2021-03-31 | -$0.19 10-Q · filed 2022-05-05 | |||||||
| 2020-12-31 | -$0.53 10-K · filed 2022-03-22 | |||||||
| 2020-09-30 | -$0.29 10-Q · filed 2021-11-04 | -$0.19 10-Q · filed 2021-11-04 | ||||||
| 2020-06-30 | $0.50 10-Q · filed 2021-08-05 | $0.22 10-Q · filed 2021-08-05 | ||||||
| 2020-03-31 | -$0.38 10-Q · filed 2021-05-06 | |||||||
| 2018-12-31 | -$1.67 10-K · filed 2019-03-14 | |||||||
| 2017-12-31 | $2.56 10-K · filed 2019-03-14 | |||||||
| 2016-12-31 | -$4.99 10-K · filed 2018-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| BIOVIE INC. (BIVI) | United States | $0.012B |